Immunitybio Inc

NASDAQ IBRX

Data sourced from iex and EODHD
Download Data

Immunitybio Inc Income Statement 2015 - 2024

This table shows the Income Statement for Immunitybio Inc going from 2015 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M 5 5 5 6 6 7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M -5 -4 -5 -6 -6 -7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
M 91 80 76 79 106 78 91 80 96 80 79 86 86 67 66 51 37 16 16 17 18 17 24 28 28 25 24 23 25 24 32 34 31 77 43 85
Selling, General, and Administrative Expenses (SG&A)
M 42 33 32 32 33 26 19 17 41 28 30 32 11 11 5 7 5 4 4 4 6 5 10 14 14 13 13 14 16 16 24 29 27 75 39 82
Research and Development (R&D) Expenses
M 53 51 48 53 79 58 72 63 55 52 49 54 41 43 36 33 27 12 12 13 13 12 15 15 14 12 11 10 9 9 8 6 5 5 4 2
Other Operating Expenses
M -4 -4 -5 -6 -6 -6 0 0 0 0 0 0 35 13 26 12 4 0 0 -1 0 0 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -3 0 0
Costs and Expenses
M 86 76 76 79 106 77 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -95 -85 -80 -85 -112 -85 -91 -80 -96 -79 -79 -86 -86 -67 -66 -51 -37 -16 -16 -17 -18 -17 -24 -28 -28 -25 -24 -23 -25 -24 -32 -34 -31 -77 -43 -85
Interest Expense
M 37 32 35 32 30 29 17 10 8 4 4 4 3 3 2 2 2 0 0 - 0 0 0 0 0 0 0 0 0 0 0 - - - 0 0
Non-operating Income/Expense
M -39 -149 -15 -21 -5 -23 -20 -15 -7 -8 -6 0 9 1 -11 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 3 0 0
EBT
M -134 -233 -96 -138 -117 -108 -111 -95 -103 -92 -88 -89 -80 -69 -68 -52 -37 -16 -16 -17 -18 -17 -24 -28 -28 -25 -24 -24 -25 -24 -32 -34 -31 -77 -43 -85
Income Tax Provision
M 0 0 -5 21 35 0 0 0 0 0 -1 0 0 0 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -134 -233 -91 -159 -151 -108 -111 -95 -103 -92 -88 -89 -80 -69 -66 -52 -37 -16 -16 -17 -18 -17 -24 -28 -28 -24 -24 -23 -25 -24 -32 -34 -31 -77 -43 -84
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 -1 -1 -1 4 -44 -32 0 - - - - - - - - - - - - - - - - - - -
Net Income
M - - - -138 -116 -108 -111 -95 -103 -91 -88 -88 -80 -36 -22 -20 -37 -22 - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 672,831,258.00 670,867,344.00 498,375,316.00 437,456,657.00 428,381,485.00 399,900,374.00 400,059,707.00 397,991,630.00 397,882,441.00 391,853,623.00 391,853,623.00 384,820,486.00 382,741,464.00 108,246,579.00 383,179,376.00 383,179,376.00 383,179,376.00 98,472,641.00 98,331,695.00 98,594,355.00 81,261,302.00 81,261,302.00 79,204,765.00 79,107,208.00 79,036,614.00 79,036,614.00 79,440,591.00 81,440,816.00 82,138,438.00 82,138,438.00 82,154,219.00 81,959,248.00 81,574,709.00 81,574,709.00 77,837,586.00 76,963,632.00
EBITDA
M -91 -80 -80 -91 -110 -83 -91 -79 -92 -76 -75 -82 -83 -65 -51 -47 -32 -13 -13 -15 -15 -15 -21 -25 -26 -23 -22 -22 -23 -23 -31 -34 -30 -77 -43 -84
Depreciation and Amortization
M 5 5 5 5 2 2 0 1 4 4 4 4 3 2 4 3 3 2 2 2 3 3 3 2 2 2 1 1 1 2 1 1 0 0 0 1
EBIT
M -95 -85 -85 -96 -112 -85 -91 -80 -96 -80 -79 -86 -86 -67 -55 -51 -35 -16 -16 -17 -18 -17 -24 -28 -28 -25 -24 -23 -25 -24 -32 -34 -31 -77 -43 -85
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.02 0.02 4.80 -15.11 -29.66 -0.03 0.20 0.26 0.17 0.00 0.90 0.00 -0.01 0.30 2.50 -0.09 -0.05 0.40 -0.03 -0.01 0.20 0.73 0.54 0.44 0.45 0.70 0.41 0.53 0.40 0.61 0.16 0.67 0.46 0.39 -0.34 0.59
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% -11,287.50 -3,183.45 -5,491.46 -15,309.76 -1,643.89 -9,321.92 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Operating Income Margin
% -237,990.00 -60,793.53 -97,726.83 -207,670.73 -30,994.44 -116,301.37 -76,952.54 -227,491.43 -685,514.29 -20,326.67 -119,448.48 -25,341.00 -62,060.43 45,840.14 -43,627.15 -11,677.98 -22,243.64 -174,366.67 -129,800.00 -98,117.65 -358,360.00 -247,471.43 -76,174.19 -693,725.00 -552,200.00 -205,208.33 -295,937.50 -167,300.00 -223,418.18 -173,928.57 -266,000.00 -285,208.33 -513,216.67 -550,878.57 -426,490.00 -92,946.15
Net Income Margin
% - - - -336,290.24 -32,317.50 -148,239.73 -94,015.25 -270,251.43 -734,471.43 -23,399.74 -132,771.21 -26,043.66 -57,276.26 24,317.01 -14,421.19 -4,608.26 -22,447.27 -247,511.11 - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% -226,602.50 -57,510.07 -97,726.83 -221,668.29 -30,496.94 -113,600.00 -76,704.24 -224,865.71 -655,971.43 -19,605.90 -113,818.18 -24,057.82 -59,830.94 44,081.63 -34,055.63 -10,789.91 -19,309.09 -149,822.22 -111,450.00 -88,811.76 -297,980.00 -207,657.14 -67,219.35 -634,500.00 -519,740.00 -192,133.33 -277,675.00 -157,485.71 -212,854.55 -160,792.86 -259,583.33 -280,933.33 -505,133.33 -547,985.71 -426,240.00 -91,859.34
EBIT Ratio
% -237,990.00 -60,793.53 -103,318.29 -233,087.80 -30,994.44 -116,301.37 -76,952.54 -227,491.43 -685,514.29 -20,527.69 -119,404.55 -25,233.04 -61,969.06 45,595.92 -36,409.27 -11,592.20 -21,406.67 -174,366.67 -129,800.00 -98,117.65 -358,360.00 -247,471.43 -76,174.19 -693,725.00 -552,200.00 -205,208.33 -295,937.50 -167,300.00 -223,418.18 -173,928.57 -266,000.00 -285,208.33 -513,216.67 -550,878.57 -426,490.00 -92,946.15
EBT Ratio
% -335,325.00 -167,952.52 -116,563.41 -337,104.88 -32,384.17 -148,345.21 -94,204.24 -270,957.14 -735,700.00 -23,474.87 -133,983.33 -26,366.67 -57,895.68 46,790.48 -44,947.02 -11,920.18 -22,672.12 -174,488.89 -129,841.67 -98,117.65 -358,420.00 -249,542.86 -76,654.84 -696,375.00 -552,860.00 -205,491.67 -300,850.00 -168,400.00 -223,754.55 -174,192.86 -266,241.67 -285,208.33 -513,216.67 -550,878.57 -426,490.00 -92,946.15

StockViz Staff

September 20, 2024

Any question? Send us an email